{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:14:07Z","timestamp":1761844447711},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T00:00:00Z","timestamp":1419033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00403-014-1532-0","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T15:59:13Z","timestamp":1419004753000},"page":"135-142","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts"],"prefix":"10.1007","volume":"307","author":[{"given":"Elham","family":"Karimizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Motamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeideh","family":"Jafarinejad-Farsangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibeh","family":"Faridani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Gharibdoost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,20]]},"reference":[{"key":"1532_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.20041393","volume":"201","author":"A Abdollahi","year":"2005","unstructured":"Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, Lee LB, McMahon G, Grone HJ, Lipson KE et al (2005) Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201:925\u2013935. doi: 10.1084\/jem.20041393","journal-title":"J Exp Med"},{"key":"1532_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-007-0008-z","volume":"9","author":"DJ Abraham","year":"2007","unstructured":"Abraham DJ, Eckes B, Rajkumar V, Krieg T (2007) New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9:136\u2013143. doi: 10.1007\/s11926-007-0008-z","journal-title":"Curr Rheumatol Rep"},{"key":"1532_CR3","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1096\/fj.07-105627","volume":"22","author":"A Akhmetshina","year":"2008","unstructured":"Akhmetshina A, Dees C, Pileckyte M, Maurer B, Axmann R, Jungel A, Zwerina J, Gay S, Schett G, Distler O et al (2008) Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J 22:2214\u20132222. doi: 10.1096\/fj.07-105627","journal-title":"FASEB J"},{"key":"1532_CR4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","volume":"171","author":"Y Aono","year":"2005","unstructured":"Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, Izumi K, Sone S (2005) Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 171:1279\u20131285. doi: 10.1164\/rccm.200404-531OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1532_CR5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/onc.2008.479","volume":"28","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Ishida W, Wu M, Wilkes M, Mori Y, Hinchcliff M, Leof E, Varga J (2009) A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate. Oncogene 28:1285\u20131297. doi: 10.1038\/onc.2008.479","journal-title":"Oncogene"},{"key":"1532_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Varga J (2012) Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 8:42\u201354. doi: 10.1038\/nrrheum.2011.149","journal-title":"Nat Rev Rheumatol"},{"key":"1532_CR7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-59745-033-1_21","volume":"419","author":"A Cheng","year":"2008","unstructured":"Cheng A, Johnson CL, Ford LP (2008) A step-by-step procedure to analyze the efficacy of siRNA using real-time PCR. Methods Mol Biol 419:303\u2013316. doi: 10.1007\/978-1-59745-033-1_21","journal-title":"Methods Mol Biol"},{"key":"1532_CR8","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","volume":"114","author":"CE Daniels","year":"2004","unstructured":"Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB (2004) Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 114:1308\u20131316. doi: 10.1172\/jci19603","journal-title":"J Clin Invest"},{"key":"1532_CR9","first-page":"56","volume":"146","author":"A Desmouliere","year":"1995","unstructured":"Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56\u201366","journal-title":"Am J Pathol"},{"key":"1532_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","volume":"56","author":"JH Distler","year":"2007","unstructured":"Distler JH, Jungel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S et al (2007) Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum 56:311\u2013322. doi: 10.1002\/art.22314","journal-title":"Arthritis Rheum"},{"key":"1532_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrm1129","volume":"4","author":"DM Dykxhoorn","year":"2003","unstructured":"Dykxhoorn DM, Novina CD, Sharp PA (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4:457\u2013467. doi: 10.1038\/nrm1129","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1532_CR12","first-page":"723","volume":"13","author":"P Fallahi","year":"2014","unstructured":"Fallahi P, Ferrari SM, Vita R, Di Domenicantonio A, Corrado A, Benvenga S, Antonelli A (2014) Thyroid dysfunctions induced by tyrosine kinase inhibitors. Expert Opin Drug Saf 13:723\u2013733. doi: 10.1517\/14740338.2014.913021","journal-title":"Expert Opin Drug Saf"},{"key":"1532_CR13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V96.3.925","volume":"96","author":"MC Heinrich","year":"2000","unstructured":"Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ (2000) Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96:925\u2013932","journal-title":"Blood"},{"key":"1532_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tcb.2003.11.003","volume":"14","author":"SE Hernandez","year":"2004","unstructured":"Hernandez SE, Krishnaswami M, Miller AL, Koleske AJ (2004) How do Abl family kinases regulate cell shape and movement? Trends Cell Biol 14:36\u201344. doi: 10.1016\/j.tcb.2003.11.003","journal-title":"Trends Cell Biol"},{"key":"1532_CR15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/09553002.2013.741281","volume":"89","author":"JA Horton","year":"2013","unstructured":"Horton JA, Chung EJ, Hudak KE, Sowers A, Thetford A, White AO, Mitchell JB, Citrin DE (2013) Inhibition of radiation-induced skin fibrosis with imatinib. Int J Radiat Biol 89:162\u2013170. doi: 10.3109\/09553002.2013.741281","journal-title":"Int J Radiat Biol"},{"key":"1532_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","volume":"14","author":"H Ihn","year":"2002","unstructured":"Ihn H (2002) Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol 14:681\u2013685","journal-title":"Curr Opin Rheumatol"},{"key":"1532_CR17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11926-005-0069-9","volume":"7","author":"H Ihn","year":"2005","unstructured":"Ihn H (2005) Scleroderma, fibroblasts, signaling, and excessive extracellular matrix. Curr Rheumatol Rep 7:156\u2013162. doi: 10.1007\/s11926-005-0069-9","journal-title":"Curr Rheumatol Rep"},{"key":"1532_CR18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","volume":"12","author":"R Kerkela","year":"2006","unstructured":"Kerkela R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ et al (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12:908\u2013916. doi: 10.1038\/nm1446","journal-title":"Nat Med"},{"key":"1532_CR19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11926-002-0008-y","volume":"4","author":"E Kissin","year":"2002","unstructured":"Kissin E, Korn JH (2002) Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis. Curr Rheumatol Rep 4:129\u2013135. doi: 10.1007\/s11926-002-0008-y","journal-title":"Curr Rheumatol Rep"},{"key":"1532_CR20","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"1532_CR21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jgm.894","volume":"8","author":"G Li","year":"2006","unstructured":"Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, Zhou H, Lu H, Jin Y (2006) Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 8:889\u2013900. doi: 10.1002\/jgm.894","journal-title":"J Gene Med"},{"key":"1532_CR22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","volume":"55","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang Z, Kwong SQ, Lui EL, Friedman SL, Li FR, Lam RW, Zhang GC, Zhang H, Ye T (2011) Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol 55:612\u2013625. doi: 10.1016\/j.jhep.2010.11.035","journal-title":"J Hepatol"},{"key":"1532_CR23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101\u20131108. doi: 10.1038\/nprot.2008.73","journal-title":"Nat Protoc"},{"key":"1532_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.cdd.4400626","volume":"7","author":"Y Shaul","year":"2000","unstructured":"Shaul Y (2000) c-Abl: activation and nuclear targets. Cell Death Differ 7:10\u201316. doi: 10.1038\/sj.cdd.4400626","journal-title":"Cell Death Differ"},{"key":"1532_CR25","first-page":"1","volume":"2","author":"A Takashima","year":"2001","unstructured":"Takashima A (2001) Establishment of fibroblast cultures. Curr Protoc Cell Biol 2:1. doi: 10.1002\/0471143030.cb0201s00","journal-title":"Curr Protoc Cell Biol"},{"key":"1532_CR26","first-page":"S59","volume":"22","author":"M Trojanowska","year":"2004","unstructured":"Trojanowska M (2004) What did we learn by studying scleroderma fibroblasts? Clin Exp Rheumatol 22:S59\u2013S63","journal-title":"Clin Exp Rheumatol"},{"key":"1532_CR27","first-page":"177","volume":"353","author":"S Tuzmen","year":"2007","unstructured":"Tuzmen S, Kiefer J, Mousses S (2007) Validation of short interfering RNA knockdowns by quantitative real-time PCR. Methods Mol Biol 353:177\u2013203. doi: 10.1385\/1-59745-229-7:177","journal-title":"Methods Mol Biol"},{"key":"1532_CR28","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/art.23648","volume":"58","author":"PL Daele van","year":"2008","unstructured":"van Daele PL, Dik WA, Thio HB, van Hal PT, van Laar JA, Hooijkaas H, van Hagen PM (2008) Is imatinib mesylate a promising drug in systemic sclerosis? Arthritis Rheum 58:2549\u20132552. doi: 10.1002\/art.23648","journal-title":"Arthritis Rheum"},{"key":"1532_CR29","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen Van den","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. doi: 10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"1532_CR30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117:557\u2013567. doi: 10.1172\/jci31139","journal-title":"J Clin Invest"},{"key":"1532_CR31","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","volume":"13","author":"F Verrecchia","year":"2007","unstructured":"Verrecchia F, Mauviel A (2007) Transforming growth factor-beta and fibrosis. World J Gastroenterol 13:3056\u20133062","journal-title":"World J Gastroenterol"},{"key":"1532_CR32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(03)14637-5","volume":"362","author":"NR Wall","year":"2003","unstructured":"Wall NR, Shi Y (2003) Small RNA: can RNA interference be exploited for therapy? Lancet 362:1401\u20131403. doi: 10.1016\/s0140-6736(03)14637-5","journal-title":"Lancet"},{"key":"1532_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-2370com","volume":"19","author":"S Wang","year":"2005","unstructured":"Wang S, Wilkes MC, Leof EB, Hirschberg R (2005) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 19:1\u201311. doi: 10.1096\/fj.04-2370com","journal-title":"FASEB J"},{"key":"1532_CR34","doi-asserted-by":"crossref","first-page":"27846","DOI":"10.1074\/jbc.M603721200","volume":"281","author":"MC Wilkes","year":"2006","unstructured":"Wilkes MC, Leof EB (2006) Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures. J Biol Chem 281:27846\u201327854. doi: 10.1074\/jbc.M603721200","journal-title":"J Biol Chem"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1532-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-014-1532-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1532-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T03:05:45Z","timestamp":1598583945000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-014-1532-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,20]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1007\/s00403-014-1532-0","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,20]]}}}